How Does Hengan International Group Company Work?

How does Hengan International Group operate at scale?

Hengan International Group transformed from China’s first sanitary napkin maker into a diversified hygiene leader, posting estimated 2025 revenue above RMB 24.8 billion. Its brands—Hearttex, Space 7 and Q•MO—drive wide market reach through retail and digital channels.

Hengan sustains 33–36% gross margins via raw-material sourcing, scale manufacturing, and premium-branding while shifting toward e-commerce and elderly-care products to capture China’s quality-growth consumers.

Explore a product-level strategic view: Hengan International Group Porter's Five Forces Analysis

Hengan International creates value through a vertically integrated model combining raw material procurement, automated manufacturing, and a multi-layered distribution network to deliver hygiene products that balance quality and accessibility.

Manufacturing Footprint

Over 40 production subsidiaries across China align factories with regional demand to reduce logistics costs and lead times.

Amoeba Management Model

Decentralized, self-accounting units empower local teams to act quickly on consumer preferences and inventory needs.

High-Speed Production Lines

Italian-engineered lines deliver consistent safety and softness for sanitary napkin and tissue segments, driving brand loyalty.

Supply-Chain Partnerships

Long-term contracts with global wood pulp suppliers hedge commodity volatility and stabilize input costs for tissue and non-woven fabrics.

The omni-channel distribution integrates over 3,000 distributors with a growing digital presence so products reach Tier-1 city consumers and rural shoppers alike; this supports stable revenue streams across urban and rural channels.

Operational Value Drivers

Core drivers include vertical integration, automation, and regionalized production that together enable cost control, product consistency, and market reach.

• Vertical integration across pulp sourcing, non-woven production, and final packaging
• Automated, high-speed lines reduce per-unit manufacturing costs
• Decentralized Amoeba units improve responsiveness and local market fit
• Omni-channel distribution with 3,000+ distributors plus ecommerce expansion

For a deeper look at strategic marketing and channel execution within Hengan International Group, see Marketing Strategy of Hengan International Group.

Hengan International Group's revenue mix in 2025 is concentrated in three pillars—Tissue Paper, Sanitary Napkins, and Disposable Diapers—supplemented by household items and exports; the Tissue Paper segment is the volume leader while sanitary napkins drive profitability.

High-volume Tissue Paper

The Tissue Paper business contributed approximately 59% of 2025 revenue through toilet rolls, facial tissues and paper towels under Hearttex; monetization emphasizes premium embossed and multi-ply SKUs to lift ASPs and margins.

Sanitary Napkins: Profit Engine

Sanitary Napkins accounted for roughly 26% of revenue but generate a disproportionately high share of operating profit with gross margins often above 60%, using tiered Space 7 pricing from mass-market to premium lines.

Diapers: Strategic Pivot

Disposable Diapers represented about 6% of revenue; brands Q•MO and ElderJoy shifted focus to premium pants-type baby diapers and the adult incontinence market amid declining birth rates.

Household & Export Growth

The remaining 9% of revenue comes from household care lines and expanding exports into Southeast Asia, targeting higher-growth emerging markets to diversify Hengan International Group operations.

Premiumization Strategy

Across segments Hengan International business model emphasizes premium SKUs, brand segmentation and value-added features (embossing, ultra-thin, overnight protection) to increase average selling price and margins.

Channel & Pricing Mix

Monetization leverages retail, e-commerce and institutional channels with tiered pricing and promotional tactics to manage trade margins and inventory across the Hengan International manufacturing process and distribution network.

Key financial levers combine volume-led tissue sales with high-margin feminine care and targeted diaper premiumization to optimize group profitability; see further analysis in the linked article below.

Revenue Strategy Highlights

Primary monetization tactics align product mix, pricing tiers and channel strategy to sustain margins and growth.

• Prioritize premium SKUs in Tissue Paper to raise ASPs and offset commodity pressure
• Leverage Space 7 sanitary napkins for high-margin volume and brand loyalty
• Shift diaper portfolio toward adult incontinence and premium pants-type baby diapers
• Expand export footprint in Southeast Asia to diversify revenue sources

Revenue Streams & Business Model of Hengan International Group

Hengan’s key milestones include its Digital Transformation 4.0 rollout, SAP and big data integration, and the 2024 full integration of a 'New Retail' unit that pushed e-commerce and O2O to over 38% of group revenue, reshaping its competitive edge through scale, brand equity, and a strong net cash position.

Digital Transformation 4.0

From early 2020s Hengan integrated SAP and big data across procurement, manufacturing and distribution to enable real-time inventory tracking and demand forecasting.

New Retail Integration

In 2024 the New Retail department was fully integrated, lifting e-commerce and O2O sales to over 38% of total group revenue and offsetting declining hypermarket foot traffic.

Supply Chain Modernization

End-to-end supply chain analytics enabled more accurate demand forecasting, reducing stockouts and lowering working capital intensity by management estimates in 2023–2024.

Strategic Financial Positioning

Maintaining a strong net cash position and steady dividend policy allowed continued R&D and tactical pricing during the 2023–2024 pulp price shock.

Hengan’s competitive edge rests on scale, brand equity and operational resilience, enabling market-share gains when rivals struggled with input cost shocks and liquidity pressure.

Key Strategic Outcomes

Concrete results include stronger online revenue mix, improved inventory turns and targeted product-mix optimization during input-price volatility.

• Over 38% of revenue from e-commerce and O2O after 2024 New Retail integration
• Real-time inventory and demand forecasting via SAP and big data across the supply chain
• Used cash reserves to optimize product mix amid 2023–2024 wood pulp price spikes, capturing share from smaller competitors
• Economies of scale and brand trust act as barriers to low-cost entrants

For a broader industry comparison and competitor analysis see Competitors Landscape of Hengan International Group.

Hengan International holds a top-tier position in China’s hygiene market with a leading ~12% share in sanitary napkins and a top-three position in tissue; risks include a shrinking infant population and margin pressure from e-commerce private labels, while the company pivots to green manufacturing and the elderly care market for future growth.

Market Position

Hengan International Group operations rank alongside global names and domestic rivals, leading sanitary napkins (~12%) and remaining a top-three tissue player in China.

Competitive Landscape

Competition spans multinational firms and nimble e-commerce-native brands; private labels on platforms like Pinduoduo exert significant pricing pressure on mass-market tissue margins.

Structural Risks

China’s declining birthrate reduces addressable volume for baby diapers; demographic headwinds are the primary downside risk to Hengan International business model growth.

Margin Pressure

Aggressive discounting by e-commerce-first brands and increasing private-label penetration compress margins across the tissue portfolio and require cost or differentiation responses.

Hengan’s strategic roadmap targets sustainable manufacturing and the aging market, leveraging manufacturing scale and its pharmacy distribution network to expand healthcare-oriented product lines.

Strategic Outlook to 2027 and Beyond

Management aims to convert structural challenges into new growth via ESG investments and the ElderJoy adult incontinence brand, targeting a double-digit revenue share by 2027.

• Investing in biodegradable materials and carbon-neutral facilities to meet China’s ESG mandates.
• Scaling adult incontinence (ElderJoy) using medical-grade production and pharmacy channels.
• Reducing cost through manufacturing efficiency and non-woven fabric integration.
• Defending tissue margins with premium SKUs and targeted e-commerce strategies.

Relevant resources include a concise company background: Brief History of Hengan International Group